The other trademarks, trade names and service marks appearing in this prospectus are the property of their respective owners.Implications of Being an Emerging Growth CompanyWe are an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. We will remain an emerging growth company until the earliest of (1) the last day of the fiscal year following the fifth anniversary of our initial public offering, or December 31, 2019, (2) the last day of the fiscal year after our annual gross revenue is $1.07 billion or more, (3) the date on which we have, during the previous three-year period, issued more than $1.0 billion in non-convertible debt securities and (4) the last day of any fiscal year in which the market value of our common stock held by non-affiliates exceeded $700 million as of the end of the second quarter of that fiscal year.2For as long as we remain an “emerging growth company,” we may take advantage of certain exemptions from various reporting requirements that are applicable to public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation and financial statements in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote to approve executive compensation and shareholder approval of any golden parachute payments not previously approved.
The forward-looking statements contained in this prospectus are made as of the date of this prospectus and we do not assume any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.10USE OF PROCEEDSWe estimate that the net proceeds from this offering will be approximately$9.0 million, based on an assumed offering price of$1.01per unit, the last reported sale price of our common stock on the NASDAQ Global Market onOctober 30, 2017, and assuming the sale of10,000,000units and no sale of any pre-funded units in this offering, after deducting the underwriting discounts and commissions and estimated offering expenses payable by us, and excluding the proceeds, if any, from the exercise of the common warrants issued pursuant to this offering.
You should read this table together with our consolidated financial statements and the related notes and the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section of our Quarterly Report on Form 10-Q for the quarter endedJune 30, 2017, filed with the SEC onAugust 14, 2017, which is incorporated by reference into this prospectus.As of June 30, 2017ActualAs Adjusted(2)(in thousands)Cash and cash equivalents$15,751$24,769Warrant liability——Preferred stock, $0.001 par value per share; 5,000,000 shares authorized and no shares issued and outstanding——Common stock, $0.001 par value per share; 200,000,000 shares authorized, 24,700,746 shares issued and outstanding(1), actual; 200,000,000 shares authorized; 34,700,746 shares issued and outstanding(1), as adjusted2535Additional paid-in capital162,564171,572Accumulated deficit(136,679)(136,679)Total stockholders’ equity25,91034,928Total capitalization$25,910$34,928(1)Shares issued and outstanding include 13,290 shares of unvested restricted common stock, which were subject to repurchase by us as ofJune 30, 2017.(2)Each $0.25 increase (decrease) in the assumed public offering price per unit would increase (decrease) the amount of cash and cash equivalents, working capital, total assets, and total stockholders’ equity by approximately$2.3 million, assuming the number of units offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting discounts and commissions and estimated offering expenses payable by us.